SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells

Katie C. Coate,Jeeyeon Cha,Shristi Shrestha,Wenliang Wang,Luciana Mateus Gonçalves,Joana Almaça,Meghan E. Kapp,Maria Fasolino,Ashleigh Morgan,Chunhua Dai,Diane C. Saunders,Rita Bottino,Radhika Aramandla,Regina Jenkins,Roland Stein,Klaus H. Kaestner,Golnaz Vahedi,Marcela Brissova,Alvin C. Powers

DOI: https://doi.org/10.1016/j.cmet.2020.11.006

IF: 29

2020-12-01

Cell Metabolism

Abstract:Isolated reports of new-onset diabetes in individuals with COVID-19 have led to the hypothesis that SARS-CoV-2 is directly cytotoxic to pancreatic islet β cells. This would require binding and entry of SARS-CoV-2 into β cells via co-expression of its canonical cell entry factors, angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2); however, their expression in human pancreas has not been clearly defined. We analyzed six transcriptional datasets of primary human islet cells and found that <em>ACE2</em> and <em>TMPRSS2</em> were not co-expressed in single β cells. In pancreatic sections, ACE2 and TMPRSS2 protein was not detected in β cells from donors with and without diabetes. Instead, ACE2 protein was expressed in islet and exocrine tissue microvasculature and in a subset of pancreatic ducts, whereas TMPRSS2 protein was restricted to ductal cells. These findings reduce the likelihood that SARS-CoV-2 directly infects β cells <em>in vivo</em> through ACE2 and TMPRSS2.

cell biology,endocrinology & metabolism